Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001062993-24-003166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-14	2024-02-12	COLL	Ciaffoni Joseph	Pres, CEO, Dir	A - Grant	$0.00	+298.7K	573.7K	+109%	$0
M	2024-02-14	2024-02-12	COLL	Ciaffoni Joseph	Pres, CEO, Dir	F - Tax	$33.70	-128.9K	526.3K	-20%	-$4.34M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-12	A	A	119,000	$0.00	394,000	D	—	—	(F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
2	Common	Common Stock	2024-02-12	A	A	179,734	$0.00	573,734	D	—	—	(F2) Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 179,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
3	Common	Common Stock	2024-02-12	F	D	81,422	$33.70	444,867	D	—	—	(F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
4	Common	Common Stock	2024-02-12	F	D	47,445	$33.70	526,289	D	—	—	(F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.